# I. Bodrogi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/i-bodrogi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,529 |
| Field | Testicular diseases and treatments |
| h-index | 30 |
| i10-index | 48 |
| Last Known Institution | Aarhus University Hospital |
| OpenAlex ID | https://openalex.org/A5045667939 |
| Works | 126 |

## Researcher papers

- [Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/temsirolimus-interferon-alfa-or-both-for-advanced-renal-cell-carcinoma/)
- [Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial](https://scholariq.org/papers/prednisone-plus-cabazitaxel-or-mitoxantrone-for-metastatic-castration-resistant/)
- [Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer](https://scholariq.org/papers/prospective-randomized-trial-of-docetaxel-versus-doxorubicin-in-patients-with/)

## Researcher topics

- [Testicular diseases and treatments](https://scholariq.org/topics/testicular-diseases-and-treatments-2/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Researcher university

- [Aarhus University Hospital](https://scholariq.org/institutions/aarhus-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.